The Trump administration is facing conflicting political pressures after Health Secretary Robert F. Kennedy Jr. said the Food and Drug Administration will "study" adding safety restrictions on abortion pills.

Why it matters: New limits like requiring in-person prescribing of the widely used abortion drug mifepristone would severely limit access to abortion in states with bans.

Between the lines: An FDA safety review sits well with many in the Republican base who are strongly anti-abortion and are pushing hard for new restrictions. • On the other hand, President Trump repeatedly pledged during the campaign last year that he would leave abortion policy to the states, to push back against Democratic charges that he would seek a nationwide ban. • Any new restrictions would face major pol

See Full Page